Camille Nelson Kotton, MD, FIDSA, FAST, is the clinical director of the Transplant and Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at Massachusetts General Hospital, and an associate professor of medicine at Harvard Medical School in Boston, MA.
Dr Kotton’s clinical interests include cytomegalovirus, vaccines, donor-derived infections, zoonoses, and travel and tropical medicine in the transplant setting. She is a recent member of the CDC Advisory Committee on Immunization Practices (ACIP) and was involved in national decisions regarding COVID-19 and other vaccines with a focused on immunocompromised patients.
Dr Kotton has served as the chair of The Infectious Disease Community of Practice of The American Society of Transplantation. She has also served as the president of The Transplant Infectious Disease Section of The Transplantation Society and highlights of her time as president include the development of 3 versions of the international guidelines on CMV management after solid organ transplant, published in Transplantation, with a fourth version underway. She is the first transplant infectious disease specialist to be elected to the executive council of The Transplantation Society.